The medical tubing market size is projected to reach US$ 23.55 billion by 2031 from US$ 13.27 billion in 2023; the market is estimated to grow at a CAGR of 7.4% during 2023–2031. The adoption of tubing with smart technology integration are likely to act as a future trend in the market in the coming years.
The use of medical tubing is on the rise in the pharmaceutical and biopharmaceutical industries. Bioprocessing involves utilizing living cells or their components to produce desired products. This process requires specialized tubing solutions to ensure efficiency, safety, and adherence to strict regulatory standards. The sterility of materials used is crucial in bioprocessing applications. Medical-grade tubing made from biocompatible materials such as silicone and thermoplastic elastomers (TPE) is essential to prevent the leaching of harmful substances into biopharmaceutical products. The increasing regulatory emphasis on product safety and efficacy drives the demand for medical tubing solutions that guarantee high levels of purity and biocompatibility during bioprocessing.
The tubing with advanced features such as biocompatibility and antimicrobial properties would generate significant growth opportunities in the medical tubing market in the future. Manufacturers can customize tubing for medical devices such as catheters, endoscopes, and infusion systems by collaborating with healthcare professionals, ultimately enhancing the functionality and effectiveness of end products. In January 2022, Otsuka Pharmaceutical Factory, Inc. introduced "Actreen," a single-use catheter with a tube and connector. It can be used by patients who have lost the urge to urinate or who opt for self-catheterization due to the difficulty faced during urinating.
The healthcare sector in China is rapidly growing due to rising health expenditures, an increasing aging population, and surging demand for medical equipment. The country is obliged to modernize its medical facilities and healthcare, which fuels the demand for quality medical devices. Medical tubing is often required in applications such as intravenous therapy, respiratory care, and surgical procedures. Innovation is a highly relevant driving force in the Chinese marketplace. Manufacturers in various healthcare industries are highly innovation oriented; they are coming up with materials and technologies with better performance, safety features, etc. Medical tubing products manufactured using biocompatible material and smart technologies are gaining significant traction in the Chinese market. Medical tubing devices integrated with smart technologies aid in the real-time monitoring of patient conditions. By mapping such potential growth avenues, key players are focusing on expanding their production bases in China and other similar markets in Asia Pacific. For instance, as per its announcement made in August 2022, DuPont added new manufacturing capacity for its silicone Liveo Pharma Tubing at its eastern China production facilities. The company also aims to boost manufacturing to produce high-purity biopharmaceutical tubing for the market in Greater China.
Medical tubing is utilized in various medical and pharmaceutical applications, including fluid management, drainage, anesthesiology, respiratory equipment, intravenous (IV) administration, catheters, peristaltic pumps, dialysis, feeding tubes, and biopharmaceutical laboratory equipment. Medical interventions that involve specialized medical tubing are often needed in the management of chronic diseases, such as diabetes, cardiovascular diseases, and cancer. In 2022, the American Cancer Society estimated 26,380 new cases of stomach cancer (gastric cancer) in the US. According to the Global Cancer Statistics published in 2022 by GLOBOCAN, the category of trachea, bronchus, and lung cancer was the most common cancer condition worldwide, followed by breast cancer and colorectal cancer, respectively. As per the International Agency for Research on Cancer (IARC), nearly 1 in 5 people would develop cancer during their lifetime, and ~1 in 9 men and ~1 in 12 women succumb to the disease. With the rising prevalence of chronic diseases, healthcare systems continuously seek medical devices such as infusion devices, catheters, and IV administration systems using tubing to effectively manage these conditions. Companies such as RAUMEDIC AG and Saint-Gobain offer a wide range of medical tubing systems for drug delivery devices, infusion devices, internal feeding systems, and peristaltic pumps. RAUMEDIC's silicone tubing is ideal for use in medical pump devices. Patients suffering from chronic diseases often require hospitalization, wherein treatment processes such as catheterization, drainage, and infusion involve the use of medical tubing. Patients with serious chronic conditions may also need surgical interventions, making medical tubing products invincible. Reliable and effective medical tubing solutions significantly contribute to patient safety and the success of treatments.
As healthcare evolves, the demand for advanced medical tubing solutions tailored to various applications is increasing. By creating tubing systems with enhanced features, such as antimicrobial properties or integrated drug delivery systems, the manufacturers can differentiate their innovations and meet evolving consumer demands. They are also focusing on medical tubing made from advanced materials that enhance flexibility, durability, and biocompatibility. Biodegradable polymers and antimicrobial coatings help meet regulatory standards while improving patient outcomes. Companies such as Trelleborg Group, Medtronic, and Saint-Gobain offer antimicrobial tubing solutions. Fresenius Kabi offers antimicrobial medical tubing aimed at intravenous therapy and enteral feeding applications; this tubing is engineered to improve patient safety by reducing microbial contamination. Thus, the creation of innovative products generates significant opportunities for manufacturers in the medical tubing market.
Key segments that contributed to the derivation of the medical tubing market analysis are type, structure, application, end user, and geography
The geographic scope of the medical tubing market report is mainly divided into 5 major regions: North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America dominated the market in 2023. Investors are increasingly focusing on companies that produce high-quality medical tubing, which serves a critical role in healthcare applications such as anesthesia delivery and fluid management. Innovative materials such as specialty polymers and biocompatible plastics determine the performance and safety of medical devices. In June 2020, Nordson Corporation acquired Fluortek, Inc., an Easton, Pennsylvania-based precision plastic extrusion manufacturer that serves the medical device industry with custom-dimensioned tubing. As Nordson MEDICAL continues expanding differentiated product offerings, the acquisition of Fluortek enhances its ability to deliver critical components that make customers' most complex medical device innovations possible. This expansion further reinforces Nordson MEDICAL's position as a component and device manufacturing capability provider for OEMs throughout the interventional, minimally invasive, and surgical medical device landscape.
The higher rate and early adoption of emerging medical technologies, coupled with the rising prevalence of chronic diseases, are likely to increase the demand for medical tubing solutions. As healthcare delivery continues to focus on efficiency and patient safety, investing in this area is expected to reap good returns and present an attractive investment avenue for growth-driven investors across the US.
The regional trends and factors influencing the Medical Tubing Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Medical Tubing Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 13.27 Billion |
| Market Size by 2031 | US$ 23.55 Billion |
| Global CAGR (2023 - 2031) | 7.4% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Medical Tubing Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Medical Tubing Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The medical tubing market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:
The "Medical Tubing Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
The List of Companies - Medical Tubing Market
Tubing with smart technology integration is expected to emerge as prime trend in the market in the coming years.
Nordson Corp, Microlumen Inc., Polyzen Inc., Accu-Tube LLC, TE Connectivity, Freudenberg Medical LLC, Compagnie de Saint Gobain SA, and Trelleborg AB are among the key players in the market.
North America dominated the market in 2023.
An increase in medical applications and expanding applications in biopharmaceutical processing are among the most significant factors fueling the market growth.
The market is expected to register a CAGR of 7.4% during 2023–2031.
The medical tubing market value is expected to reach US$ 23.55 billion by 2031.